roflumilast
astrazeneca
['psoriasis', 'roflumilast']
new late-breaking #aad23 data showed that oral roflumilast was both safe &amp; efficacious against #psoriasis, making it a potentially less expensive treatment alternative. check out the trial results here: #plaquepsoriasis #aad2023
Clinical News for Connected Physicians. Everything you need to enhance your clinical approach to improving patient care.